CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma

NCT00044018 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
102
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene